dc.contributor
Institut Català de la Salut
dc.contributor
[Trigo J] HC Marbella International Hospital, Spanish Society of Medical Oncology (SEOM), Marbella, Spain. [García-Cosío M] Ramón y Cajal University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [García-Castaño A] Marqués de Valdecilla University Hospital, Spanish Society of Medical Oncology (SEOM), Santander, Spain. [Gomà M] Bellvitge University Hospital, Spanish Society of Pathological Anatomy (SEAP), Hospitalet de Llobregat, Spain. [Mesia-Nin R] Catalan Institute of Oncology (ICO), Badalona Applied Research Group in Oncology, Germans Trias i Pujol Research Institute, Spanish Society of Medical Oncology (SEOM), Badalona, Spain. [Ruiz-Bravo E] La Paz University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [Braña-García I] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Society of Medical Oncology (SEOM), Barcelona, Spain. [Alberola-Ferranti M] Vall d’Hebron Hospital Universitari, Spanish Society of Pathological Anatomy (SEAP), Barcelona, Spain
dc.contributor
Departament de Salut
dc.contributor.author
Trigo, José Manuel
dc.contributor.author
Garcia-Cosio, Monica
dc.contributor.author
García‑Castaño, Almudena
dc.contributor.author
Gomà, Montserrat
dc.contributor.author
Mesia, Ricard
dc.contributor.author
Ruiz‑Bravo, Elena
dc.contributor.author
Braña Garcia, Irene
dc.contributor.author
Alberola Ferranti, Margarita
dc.date.accessioned
2025-10-24T10:42:45Z
dc.date.available
2025-10-24T10:42:45Z
dc.date.issued
2022-09-12T09:54:26Z
dc.date.issued
2022-09-12T09:54:26Z
dc.identifier
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, et al. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clin Transl Oncol. 2022 Oct;24:1890–902.
dc.identifier
https://hdl.handle.net/11351/8153
dc.identifier
10.1007/s12094-022-02856-1
dc.identifier
000814957700002
dc.identifier.uri
https://hdl.handle.net/11351/8153
dc.description.abstract
Epstein Barr virus; Prognosis; Response to treatment
dc.description.abstract
Virus de Epstein Barr; Pronóstico; Respuesta al tratamiento
dc.description.abstract
Virus d'Epstein Barr; Pronòstic; Resposta al tractament
dc.description.abstract
The treatment of head and neck and salivary gland tumours is complicated and evolves constantly. Prognostic and predictive indicators of response to treatment are enormously valuable for designing individualized therapies, which justifies their research and validation. Some biomarkers, such as p16, Epstein–Barr virus, PD-L1, androgen receptors and HER-2, are already used routinely in clinical practice. These biomarkers, along with other markers that are currently under development, and the massively parallel sequencing of genes, ensure future advances in the treatment of these neoplasms. In this consensus, a group of experts in the diagnosis and treatment of tumours of the head and neck and salivary glands were selected by the Spanish Society of Pathology (Sociedad Española de Anatomía Patológica—SEAP) and the Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica—SEOM) to evaluate the currently available information and propose a series of recommendations to optimize the determination and daily clinical use of biomarkers.
dc.description.abstract
SEOM and SEAP acknowledge the financial support for this project in the form of unrestricted collaboration in the logistics from AstraZeneca.
dc.format
application/pdf
dc.relation
Clinical and Translational Oncology;24
dc.relation
https://doi.org/10.1007/s12094-022-02856-1
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Marcadors bioquímics
dc.subject
Glàndules salivals - Càncer
dc.subject
DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms
dc.subject
DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Mouth Neoplasms::Salivary Gland Neoplasms
dc.subject
CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Biomarkers, Tumor
dc.subject
ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello
dc.subject
ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello::neoplasias de la boca::neoplasias de las glándulas salivales
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::marcadores tumorales
dc.title
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
